Related Experiment Video

Updated: Jul 20, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

Eriocalyxin B inhibits nuclear factor-kappaB activation by interfering with the binding of both p65 and p50 to the

Chung-Hang Leung1, Susan P Grill, Wing Lam

  • 1Department of Pharmacology, School of Medicine, Yale University, 333 Cedar Street, New Haven, CT 06520-8066, USA.

Molecular Pharmacology
|August 31, 2006
PubMed

Insights

Eriocalyxin B (Eri-B), a natural compound, potently inhibits nuclear factor-kappaB (NF-kappaB) by blocking its DNA binding. This discovery offers a new therapeutic strategy for inflammatory and autoimmune diseases.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Immunology

Background:

  • Nuclear factor-kappaB (NF-kappaB) is crucial in cell survival and inflammation.
  • NF-kappaB is a key drug development target for cancer, inflammatory, and autoimmune diseases.

Purpose of the Study:

  • To investigate the NF-kappaB inhibitory potential of eriocalyxin B (Eri-B), a novel ent-kauranoid.
  • To elucidate the mechanism of action of Eri-B as an NF-kappaB inhibitor.

Main Methods:

  • NF-kappaB transcriptional activity assays.
  • Chromatin immunoprecipitation (ChIP) assays.
  • In vitro DNA binding assays.

Main Results:

  • Eri-B selectively inhibited NF-kappaB transcriptional activity without affecting cAMP response element-binding protein.
  • Eri-B suppressed NF-kappaB downstream genes (COX-2, iNOS) in response to TNF-alpha or LPS.
  • Eri-B blocked NF-kappaB DNA binding in vivo and in vitro without affecting nuclear translocation.

Conclusions:

  • Eri-B is a potent NF-kappaB inhibitor with a novel mechanism of action, targeting DNA binding.
  • Eri-B's unique structure, featuring alpha,beta-unsaturated ketones, contributes to its inhibitory activity.
  • Further structural modification of Eri-B analogs may lead to tailored treatments for NF-kappaB-associated diseases.

More Related Videos

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells10:57

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells

Published on: January 12, 2020

Related Concept Videos

Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...